Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Xenikos
company
About
Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.
- 1 - 10
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Xenikos aims to develop a new medicine, based on the action of antibodies that enables patients suffering serious immune diseases, or rejection after transplantation, to reset their immune system quickly and efficiently. Xenikos strives to develop new, innovative immunotherapy medicines to help restore patients’ health and save lives.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
€45.50M
Xenikos has raised a total of
€45.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | Grant | — | 1 |
European Innovation Council
|
— | Detail |
| Sep 8, 2021 | Convertable Note | €40M | 1 | — | — | Detail |
| Jun 19, 2012 | Debt Financing | €1.90M | 1 |
|
— | Detail |
| Jun 19, 2012 | Series A | €3.60M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Xenikos is funded by 4 investors.
European Innovation Council
and Agentschap NL
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Grant |
|
|
Yes | Debt Financing |
|
|
— | Convertable Note |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
